Next Article in Journal
Age and Growth of Pacific Sardine (Sardinops sagax) off the U.S. Pacific Coast, 2012–2021
Previous Article in Journal
Revealing Ontogenetic Vertical Migration in Deep-Sea Grenadiers (Macrouridae) from the Southwestern Atlantic Through Otolith Microchemistry
Previous Article in Special Issue
Effects of Different LED Lights on the Growth Performance and Serum Lysozyme Activity of Common Carp Cyprinus carpio and Bacterial Communities in a Closed Recirculating System
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Monoterpenes as Natural Anesthetics to Mitigate Stress in Fish: Advances Using the Zebrafish Larvae Model

by
Raquel S. F. Vieira
1,*,†,
Cláudia A. Rocha
2,†,
Carlos A. S. Venâncio
2,3,4 and
Luís M. Félix
2,*
1
School of Life and Environmental Sciences (ECVA), University of Trás-os-Montes and Alto Douro (UTAD), 5000-801 Vila Real, Portugal
2
Centre for the Research and Technology of Agro-Environment and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), 5000-801 Vila Real, Portugal
3
Department of Animal Science, School of Agrarian and Veterinary Sciences (ECAV), University of Trás-os-Montes and Alto Douro (UTAD), 5000-801 Vila Real, Portugal
4
Animal and Veterinary Research Centre (CECAV), University of Trás-os-Montes and Alto Douro (UTAD), 5000-801 Vila Real, Portugal
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Fishes 2026, 11(5), 289; https://doi.org/10.3390/fishes11050289
Submission received: 3 March 2026 / Revised: 2 April 2026 / Accepted: 6 May 2026 / Published: 13 May 2026
(This article belongs to the Special Issue Fish Health and Welfare in Aquaculture and Research Settings)

Abstract

During production, fish are exposed to multiple environmental, physiological, and physical stressors, which compromise development, productivity, and welfare and urge the implementation of effective and safe stress-mitigating strategies, particularly during early developmental stages. Larval zebrafish (Danio rerio) constitute a powerful model for studying acute stress responses due to the numerous advantages they offer, such as developmental transparency, a conserved hypothalamic–pituitary–interrenal (HPI) axis, and suitability for high-throughput screening. This review examines the potential of natural monoterpenes as stress-reducing compounds and compares their performance with conventional synthetic anesthetics. Evidence from vortex-flow stress paradigms, behavioral profiling and biochemical assays shows that acute stress in zebrafish larvae triggers metabolic disruption, behavioral hyperactivity and enzyme imbalance, with cortisol responses depending on stimulus intensity. Monoterpenes such as thymol and menthol consistently reduce stress-induced hyperactivity, support redox homeostasis and display favorable safety profiles at low doses and short exposures. Nevertheless, as research into these substances is still recent, evidence of any potential adverse effects is still limited. Although individual monoterpenes may act on different subsets of molecular targets, their multimodal mechanisms, including gamma-aminobutyric acid (GABA)ergic enhancement, voltage-gated ion channel and transient receptor potential (TRP) modulation, suggest broader and potentially safer actions compared to single-target anesthetics as tricaine methane sulfonate (MS-222). Collectively, these findings suggest that monoterpenes offer promising natural alternatives for stress mitigation in aquaculture and the refinement of research procedures involving early life stages.
Key Contribution: This review highlights the value of zebrafish larvae as a robust model for investigating stress and anesthesia in fish, while critically examining the mechanisms and limitations of synthetic anesthetic agents, ultimately exploring the potential of plant-based monoterpenes as safer and effective alternatives for fish anesthesia and stress mitigation.

Graphical Abstract

1. Introduction

Aquaculture is the fastest-growing food-production sector worldwide, yet routine procedures such as grading, transport, vaccination or sampling, frequently expose fish to acute or chronic stress, which significantly impacts both welfare and performance. Therefore, strategies to mitigate stress responses are essential for both ethical and practical reasons. In this context, zebrafish (Danio rerio) larvae have become powerful models to investigate stress responses and anesthetic mechanisms in fish, due to their conserved HPI axis, optical transparency, and high-throughput suitability, allowing for a broader range of studies that are difficult to perform in commercial aquaculture species.
Chemical anesthetics, such as tricaine methanesulfonate (MS-222) and benzocaine, are widely used as standard fish anesthetics. However, these are often associated with adverse effects and regulatory restrictions, prompting the search for natural alternatives. Among these, monoterpenes, including eugenol, thymol and menthol, have emerged as promising candidates due to their reported anesthetic, anxiolytic, antioxidant and anti-inflammatory properties. Nevertheless, the diversity of compounds and the variability in experimental conditions require a systematic assessment of their mechanisms and applicability before their implementation as effective and safe anesthetics.
This review synthesizes current evidence on (1) stress physiology in fish, (2) the use of zebrafish larvae as a model for stress and anesthesia research, and (3) the potential of monoterpenes as natural anesthetics to mitigate stress in zebrafish larvae up to 5 days post-fertilization (dpf), in line with the European Directive 2010/63/eu. By restricting the scope to zebrafish larvae, this review allows for a more robust and standardized comparison of results across studies. In addition, mechanistic insights, comparative efficacy, limitations of existing studies and key research gaps to guide future applications in aquaculture and welfare-oriented practices are also addressed.

2. Stress Physiology in Fish

2.1. Functioning and Description of the Hypothalamus–Pituitary–Interrenal (HPI) Axis

The hypothalamus–pituitary–interrenal (HPI) axis is the central neuroendocrine pathway regulating the stress response in fish and is functionally analogous to the hypothalamus–pituitary–adrenal (HPA) axis in mammals [1,2,3]. Environmental or physiological stressors are first detected by the central nervous system (CNS) and integrated at the level of the hypothalamus, which responds by releasing the corticotropin-releasing hormone (CRH) and associated peptides [4,5] (Figure 1). These neurohormones stimulate the anterior pituitary to synthesize and secrete the adrenocorticotropic hormone (ACTH) into the circulation [6,7]. ACTH then targets the interrenal cells located in the anterior kidney (head kidney), where it activates steroidogenic pathways leading to the production and release of cortisol, the principal glucocorticoid in teleost fish [1,7]. The activity of the HPI axis is tightly regulated through negative feedback mechanisms, whereby elevated circulating cortisol acts on both the hypothalamus and pituitary to inhibit further CRH and ACTH release and prevent prolonged or excessive activation of the stress response [3,6]. In addition to cortisol secretion, stress exposure also activates the brain–sympathetic–chromaffin (BSC) system, which promotes the rapid release of catecholamines, mainly adrenaline and noradrenaline, from chromaffin tissue associated with the head kidney [2,8]. While catecholamines mediate the immediate “fight-or-flight” response, cortisol exerts longer-lasting effects by modulating gene transcription and coordinating metabolic, osmoregulatory, and immune processes [1,7].
Through the integrated action of these hormonal components, the HPI axis orchestrates a cascade of physiological adjustments that allows fish to cope with challenging conditions [2,9]. These adjustments are traditionally categorized into three hierarchical levels of response: the primary response, involving the release of stress hormones; the secondary response, encompassing downstream physiological and biochemical changes; and the tertiary response, which reflects whole-organism consequences such as altered growth, reproduction, and behavior [1,2,7].

2.2. Physiological Responses to Stress

Together, the HPI and the BSC axis regulate the primary, secondary and tertiary responses to stress. Primary responses involve neuroendocrine activation, particularly of the HPI axis, resulting in the release of stress hormones such as cortisol and catecholamines [10]. Secondary responses comprise downstream physiological and biochemical alterations that include changes in energy metabolism and ion regulation such as increased plasma glucose, lactate, and hematocrit, as well as reduced chloride (Cl), sodium (Na+), and potassium (K+) levels [2,7]. In turn, tertiary responses arise as a consequence of prolonged or repeated secondary responses and may manifest as impaired growth, reproductive dysfunction, alterations in immune function, increased susceptibility to disease, behavioral changes, and even mortality [9,11]. Therefore, these effects are frequently associated with chronic or continuous stress rather than with acute stress exposure.
These responses can be triggered by a wide variety of stressors, including environmental, biological, and husbandry-related factors, whose nature and intensity determine the magnitude and duration of the stress response. Understanding the physiological mechanisms underlying these responses is therefore essential for identifying and mitigating key stress-inducing conditions, particularly during critical procedures such as fish transport.

2.3. Stress-Inducing Factors in Aquaculture

In aquaculture, fish are exposed to multiple stressors from early developmental stages to adulthood, as cultured fish are continuously subjected to husbandry-related, environmental, physical and physiological challenges [12]. These stressors are usually divided into three broad categories: environmental, biological, and physical stress [13,14] (Figure 2). Although this classification is useful, it is important to note that responses to stress may differ between species.
Environmental stressors are frequently encountered under farming conditions, to which ornamental species such as zebrafish are often exposed [12,15]. Exposure to stressors is particularly relevant during early development stages, as it may lead to long-term physiological and behavioral alterations that can be epigenetically transmitted to offspring, thereby influencing stress sensitivity in subsequent generations and highlighting the importance of managing stress at both the individual level and within breeding programs [16,17,18,19,20]. Nevertheless, while some stressors can be mitigated through improved management practices, such as gentle handling, optimized water quality, and appropriate stocking densities, others remain unavoidable due to production cycles and seasonal environmental variability and must be addressed through alternative strategies [21,22].
Among the various stressors encountered in aquaculture, transportation represents one of the most critical challenges and is consistently shown to induce osmotic imbalance and ion loss in several freshwater fish species [23,24,25]. Fish, particularly ornamental species, are typically transported in plastic bags filled with water often pre-treated with chemical additives or medications (e.g., salt and artificial or natural anesthetics) to reduce metabolic activity and stress and saturated with pure oxygen, sealed and placed in insulated containers [26,27]. Transport duration ranges from short periods (2 to 4 h) [28] to extended journeys lasting up to 72 h [29], with road transport being the most common mode [30,31]. Notably, the outcomes of transport are highly dependent on context, and its success depends on several interacting factors, including journey duration, water quality, fish size and density, temperature, physiological condition, and the depuration period prior to transport [32,33]. Moreover, fish are exposed to multiple stress-inducing conditions, such as agitation, noise, environmental fluctuations, and deterioration of water quality, particularly in terms of oxygen availability. These factors can trigger rapid endocrine responses characterized by elevated cortisol levels [2], disruption of ion homeostasis, increased oxidative stress [30], altered energy metabolism, accumulation of stress metabolites, and behavioral disturbances [32,34,35,36] that activate compensatory physiological mechanisms aiming to restore internal homeostasis [37]. Physical injuries, such as scale loss and mucus depletion, are also common during transport and consequently increase susceptibility to bacterial and fungal infections [38]. Although most transport-related studies have been conducted in different species, these stressors are also very important for zebrafish, which are widely transported both within the ornamental fish trade and between research facilities [39]. As a result, recent studies have emphasized the urgent need to improve welfare standards during transport of aquatic animals [40,41,42,43,44], considering transport-related stress is associated with compromised health and increased mortality rates, especially in ornamental species subjected to repeated handling and prolonged confinement [33,45].
Given the complexity and intensity of stress responses induced by transportation and other husbandry practices, the use of suitable experimental models is essential to investigate stress physiology and develop effective mitigation strategies. In this context, zebrafish have emerged as a valuable model organism for studying stress and anesthesia-related processes [46] under controlled laboratory conditions.

3. Zebrafish as a Model for Stress and Anesthesia Research

3.1. Advantages of the Zebrafish Model for Aquaculture Research

The use of zebrafish as an animal model for aquaculture studies has grown exponentially over the years [47,48,49,50]. This fish model offers numerous advantages, including low costs and relatively easy maintenance, large number of offspring and replicates per assay, and a lack of legal restrictions up to 120 h post-fertilization (hpf) [51], as well as the fact that major neurotransmitters can be found by 72 hpf [48,52], making the larvae a useful model in the stress and anesthesia field [48]. Zebrafish also exhibit advantageous biological characteristics that are representative of a broader range of aquatic species [53] and have thus been used to investigate the neurological, behavioral, and metabolic pathways highly conserved across them [38,48,54,55,56]. Although other species are commercially relevant, their larger size, slower development, and more complex husbandry requirements often limit their applicability in fundamental anesthesia research, making zebrafish an invaluable model for both scientific exploration and practical applications in fish procedures [46].
Zebrafish are used in the most diverse areas ranging from nutrition to immunological studies [6,49,50,53,57,58]. In addition, zebrafish have increasingly been used as models to assess welfare in aquaculture and for testing compounds aimed at reducing stress and improving welfare [51,59,60,61,62]. Early developmental stages have received particular attention due to their high sensitivity to compounds and external stimuli [63,64] and taking into account that stress at this stage can have lasting effects on growth and health [65,66,67,68]. Some studies corroborate this by demonstrating that zebrafish larvae are sensitive to stimuli such as vortex and agitation from 96 hpf, exhibiting behavioral, metabolic, and even genetic changes (Table 1) [6,64,69].

3.2. Zebrafish Larvae as a Model for Stress Research

One of the first studies using the zebrafish larvae model to study stress was conducted by Alsop and Vijayan [6], aiming to verify the development of the corticosteroid axis and the expression of corticoid receptors using different types of stress in larvae of different ages, with the earliest stage tested being 25 hpf [6]. Although the production of cortisol and activation of the HPI axis were clear from the moment of hatching, acute cortisol responses to stressors were not detected until 97 hpf, indicating that the HPI axis only becomes functionally responsive around 72 hpf. These findings were confirmed in another study, demonstrating that despite the early expression of all HPI axis components and the synthesis of cortisol at hatch, a stressor-induced cortisol response only becomes apparent at the same time (97 hpf) [70]. Collectively, these studies highlight the discrepancy in responses between larvae stages and reinforce the importance of considering development stages when interpreting stress physiology in zebrafish.
Faught and Vijayan [66] later established that this model was also a good basis for studying the mineralocorticoid receptor and the regulation of the HPI axis, by quantifying cortisol levels at different development stages, 2, 24, 48, and 96 hpf, with the latest stage being subjected to an acute swirling stressor. The study showed that both glucocorticoid (GCR) and mineralocorticoid (MR) receptors are involved in stress-related behaviors, as the loss of receptors abolished the glucocorticoid-mediated hyperactivity in response to a light stimulus [66]. In a subsequent study, the author confirmed that the CRH/CRHR1 system induces hyperactivity, while cortisol production and subsequent GCR/MR signaling are required to sustain this response [71]. Additional findings by Castillo-Ramírez et al., (2019) [72] also demonstrated that vortex speed might also induce speed-dependent stress responses with activation of cortisol-independent pathways in larval zebrafish using high-throughput forced swimming tests. These results align with mammalian models and offer an important framework for additional research on the early-life cortisol responses and feedback of zebrafish larvae, which are perfect for high-throughput screening and non-invasive imaging [73].
Recently, in a study conducted using vortex-flow methods with adaptations, it was possible to observe that acute stress in 96 hpf larvae increases metabolic rate, distance swum and speed [74]. Yet cortisol, glucose, and lactate levels remain unaltered [74]. At the biochemical level, the activity of both ATPase and glutathione S-transferase (GST) decreased, potentially due to alterations in osmoregulation associated with the hypothetical adrenocorticotropic hormone downregulation. Further advances have been made using molecular markers of stress, including associated immediate early genes and components of the stress axis, as well as urotensin 1, corticotropin-releasing hormone-binding protein, and succinate dehydrogenase [68]. This work was recently reviewed and compared with De Marco et al., (2025) [65], demonstrating that zebrafish larvae exhibit detailed cortisol response patterns, rapid regulation mediated by GC receptors, developmental modulation of the HPI axis function, and reduced cortisol reactivity. Collectively, these findings support the use of the vortex stimuli in zebrafish larvae as an innovative and reproducible option that respects ethical principles and fits within the 3Rs policy to study stress mechanisms and adaptive responses in vertebrate models [65]. In addition, the use of the zebrafish larvae model to assess changes in the HPI axis with the potential to interfere at the behavioral, metabolic, and physiological levels is increasingly justified by the literature. Adding to the similarity between the HPI and HPA axes, this model offers versatility and allows for coherent and clear results on what happens when fish are subjected to a stressful situation. Nevertheless, selecting any model to evaluate the effects of stress in aquatic animals must still consider several factors, such as its sensitivity to the stimulus and the extrapolation across species [75].
As these findings clearly establish that the HPI axis is functionally active and responsive to environmental stimuli from early development stages, developing and implementing effective anesthesia strategies becomes critical. Nevertheless, research on the topic is very limited when it comes to embryos or larvae.

3.3. Zebrafish Larvae as a Model for Anesthesia Research

To answer the urgent need for strategies to minimize stress in fish species, zebrafish larvae represent an important model to investigate both the efficacy of anesthetic substances, as well as their potential to modulate stress-related responses. In aquaculture and research settings, anesthesia is often implemented to reduce stress arising from multiple sources. Yet, since the effects of these substances depend on concentration, exposure time, mechanism of action, and even development stage, it becomes essential to understand the balance between all these factors to ensure welfare-oriented practices.
Responses to anesthetic compounds and stressors can vary depending on the development stage [76,77,78,79], reflecting differences in metabolic rate, oxygen consumption, and sensitivity to drugs during ontogeny [80]. As a result, effective concentration, induction time, and recovery of anesthetics, as well as their absorption, also differs between embryo–larval stages and more developed stages, such as juvenile and adult [76,81]. Using larvae for initial screening allows the evaluation of potential side effects, optimization of concentrations, and assessment of physiological and molecular responses, thereby serving as a replacement for other, more complex models [63,82]. In this context, a wide range of anesthetic agents—synthetic and natural—have been explored in zebrafish larvae [77,83,84,85]. The use of this model has also become relevant in other fields, such as analgesia and euthanasia, highlighting its versatility [86,87,88].
These findings position zebrafish larvae as a relevant and robust model to further explore the role of conventional synthetic anesthetics as stress-mitigating strategies, while allowing for the investigation of emerging natural alternatives.

4. Synthetic vs. Natural Anesthetics for Fish

4.1. Anesthesia as a Strategy to Reduce Stress

During fish procedures, different strategies have been explored to reduce stress during handling and transportation. Most approaches, including control of osmoregulatory balance, levels of dissolved oxygen and carbon dioxide, suspended solids and ammonia, temperature, and carrying capacity, as well as reducing physical handling and fish acclimatization, have been applied primarily to the juvenile and adult stages, as the small size and fragility of larvae have traditionally limited their use. Despite this, recent research indicates that early developmental stages may also serve as reliable models, given the comparable sensitivity of larvae and adults to stressors [76,81]. Within this scope, multiple natural and synthetic substances have been investigated for use during anesthetic procedures, with variations in licensing across countries. Currently, only MS-222 is approved for use on food fish by the United States Food and Drug Administration’s Centre for Veterinary Medicine, with a required 21-day withdrawal period [89]. However, this varies internationally and may extend up to 70 days [90]. In contrast, eugenol has been licensed as an aquatic anesthetic in several countries, including South Africa and New Zealand where no withdrawal period is necessary, and Japan where it has a 7-day withdrawal requirement [90].
Anesthesia has three levels, sedation, general anesthesia, and deep anesthesia [46]. While sedation is characterized by depression of awareness, suppression of the fish receptiveness to external stimuli, and limited arousal responses, the remaining phases result in inhibition of reflex activity and reduced skeletal muscle tone [88,91,92,93]. An ideal anesthetic should be environmentally friendly, non-toxic to fish, effective in under three minutes while facilitating immediate recovery (<5 min), easily accessible, reasonably priced, and leave no remnant in tissues [94,95].
The use of anesthetics has gained attention as a practical strategy given their ability to reduce metabolism, oxygen consumption, carbon dioxide and ammonia production, thereby reducing stress from handling and capture and improving animal welfare overall [33,96]. While some compounds with sedative properties exhibit tranquilizing, anxiolytic, and in some cases analgesic capacities [97], others of natural origin may provide additional benefits, such as antioxidant and antiseptic effects, and may even improve immune function [98,99]. However, the use of these substances in larvae remains unclear, particularly regarding the appropriate dosage which can vary considerably depending on species, size, and development stage [100]. In addition, most anesthetic substances used are often associated with notable adverse effects that should not be overlooked.

4.2. Aversive Properties of Conventional Anesthetics

The most common anesthetics in early developmental stages include MS-222, benzocaine, etomidate, propofol, quinaldine sulfate, eugenol and its isomer, isoeugenol (Table 2). However, with increased use and consequent research regarding conventional anesthetic agents, the literature is being filled with articles that address the adverse effects of these compounds [99,101,102].
MS-222 exhibits its anesthetic effects through a voltage-gated Na+ channels blockade [104]. This compound has an acidic nature and requires buffering before it can be used, ultimately increasing preparation time and potentially inducing physiological alterations in fish depending on the buffering agent [100,106]. Although this substance is described as a better option than gradual cooling, another commonly used anesthetic method [107], MS-222 is also associated with adverse cardiac effects [104], namely concentration-dependent reductions in both atrial and ventricular rates, stroke volume and cardiac output, which corroborates the cardiovascular stress typically observed in conventional anesthetics [103]. In addition, alterations in locomotion and optokinetic behavior have also been documented. Interestingly, zebrafish larvae reveal differential sensitivity to this anesthetic that increases with developmental stage and reinforces the pressing need to establish stage-specific dosing regimens for this compound. Nevertheless, other relevant effects manifest on the toxicological level, as exposure to this anesthetic in zebrafish larvae reveals a range of physiological, biochemical, teratogenic and behavioral effects [104].
Benzocaine is a low-cost local anesthetic that provides light anesthesia by blocking voltage-sensitive Na+ channels [83,108,109,110]. However, its role as an anesthetic for larvae remains debatable. Dimitriadou et al., (2025) [103] reported that this substance depresses atrial and ventricular rates and cardiac output, significantly impacting cardiovascular function. Additional findings demonstrate that benzocaine induces anxiety-like behavior as confirmed through increased thigmotaxis in the dark phase, which ultimately overtakes its practicability.
Propofol, a short-acting sedative-hypnotic agent commonly used for induction and maintenance of anesthesia, modulates GABA receptors and increases conductance of CL-channels [103]. Studies in zebrafish embryos have demonstrated that propofol exposure induces stage-dependent developmental toxicity, as well neurological and cardiovascular effects [105,111].
Regarding quinaldine sulphate, although its precise mechanism of action remains unclear, its anesthetic and adverse effects in zebrafish larvae have been reported [112,113]. Notably, in the study by Dimitriadou et al., (2025) [103] this compound was the only one to elicit clear aversion behavior to the administered site. In the same study, etomidate, another GABAergic anesthetic, produced a limited anesthetic effect but still revealed significant adverse effects. This suggests that even moderate anesthesia from synthetic substances may still impact the cardiovascular system in larvae.
In general, the use of synthetic anesthetic agents is associated with prolonged induction and recovery times, as well as a numerous list of adverse effects that mainly affect the cardiorespiratory system [103]. These effects can lead to states of bradycardia, hypoxia, and blood acidosis, alter glucose, lactate, cortisol, and other biochemical parameters, and cause enzymatic, behavioral, and developmental changes. Nevertheless, it is important to acknowledge that the magnitude of these effects may be dependent on experimental conditions, including different anesthetic concentrations and exposure times. For instance, in the study by Leyden et al., (2022) [104], zebrafish were exposed to MS-222 for 7 min, whereas a longer exposure duration were applied in another similar study [103], which may contribute to differences in the reported severity of adverse effects. Considering the primary focus of most studies is on the biological effects of the compounds rather than on standardized exposure protocols, this leads to divergent exposure duration and administered dosage across studies, consequently limiting direct comparisons of the reported effects. Additionally, although all studies included here were conducted in zebrafish larvae, it is also important to note that sensitivity to these compounds may also vary across species and that both dose- and species-dependent effects are important aspects in toxicological assessment.
Over the years, the focus has shifted to replacing these compounds and others similar to them with compounds of natural origin [111,113,114]. Among these, the most extensively investigated are monoterpenes eugenol and isoeugenol, the main components of clove oil (Syzygium aromaticum). These substances exhibit a wide range of biological properties [37,99,115,116], as well as good anesthetic capacity in both zebrafish embryos and larvae [117,118,119,120,121]. Nevertheless, their use may also be associated with adverse effects at some concentrations, urging the need to expand research into other monoterpenes [76,122].

4.3. Monoterpenes as Alternative Stress-Reducing and Anesthetic Agents

The use of herbal compounds with anesthetic properties has recently gained attention, mainly due to the need for alternatives to conventional synthetic anesthetics and the numerous advantages they offer, including minimal aversion and behavioral changes [46]. Multiple plant species contain compounds with potential anesthetic properties, such as Lippia alba, Melaleuca alternifolia, Aloysia triphylla, Ocimum americanum, Ocimum gratissimum, Thymus vulgaris, and Mentha piperita, among others, as reviewed by Minaz and Félix, (2026) [46]. However, studies evaluating their efficacy in early stages of development, particularly in zebrafish larvae, are still very limited [46]. In this context, monoterpenes—volatile compounds often present in the essential oils of these plants—have been the most extensively investigated substances, including cineole, menthol, thymol, eugenol, myrcene, linalool, geraniol, citronellal, citral and terpinene-4-ol [76,84,122,123,124].
The mechanisms of action of monoterpenes are closely associated with their chemical structure, high lipophilicity, and interactions with biological receptors [90,125,126]. Their ability to integrate into the neuronal lipid bilayer and alter membrane fluidity may complement their direct binding to transmembrane proteins, potentially influencing the conformational transitions of ion channels [126]. Because they share structural similarities, monoterpenes generally exhibit comparable modes of action across different bioactivities (Figure 3) [127,128,129]. In terms of analgesic capacity, phenolic monoterpenes show affinity for the gamma-aminobutyric acid (GABA) [84,129,130] and transient receptor potential vanilloid-1 (TRPV1) receptors [131]. GABA receptors play a key role in pain processing, analgesia, depression, and anesthesia [132,133,134]. Specifically, positive allosteric modulation of GABA receptors, which mediate the main inhibitory neurotransmission in the CNS, suppresses neuronal activity and leads to CNS depression and anesthesia [132,135]. Recent evidence in fish models suggests that monoterpenes like thymol may interact with the GABAA receptor complex at sites distinct from those of benzodiazepines, as their effects are often sensitive to picrotoxin but not flumazenil [125,136]. Monoterpenes with anesthetic properties act in a similar manner, primarily through modulation of the GABA receptor complex [132,135,137,138,139], and modulate various ion channels, including TRPV1 [140,141,142,143,144], and voltage-gated Na+ and Ca2+ channels [145]. The interaction with voltage-gated Na+ channels typically involves the stabilization of the inactivated state, preventing the rapid depolarization required for nociceptive signaling [146]. This multimodal action, characterized by the simultaneous inhibition of excitatory pathways and enhancement of inhibitory neurotransmission, resembles that of local anesthetics such as benzocaine and lidocaine [119,135,137,147]. Furthermore, in aquatic species, the rapid onset and recovery associated with these compounds are attributed to their efficient absorption across the gill epithelium and subsequent passage through the blood–brain barrier [94,125].
Despite advancements, research on the molecular mechanisms through which monoterpenes exhibit their anesthetic effects is still fresh, highlighting the need for further studies to validate their use in fish and improve our understanding of their physiological impacts in zebrafish larval stages [92,93,135,148]. Nevertheless, research into this topic is growing—supported by the inherently favorable effects of these compounds [90].

4.4. Physiological Effects and Applications of Monoterpenes

In a recent study, Capparucci et al., (2022) [123] demonstrated that both clove oil, which is rich in eugenol, and AQUI-S, constituted by 50% of isoeugenol, produced effective sedation in zebrafish embryos and larvae, although differences in induction and recovery times indicated a developmental dependence on physiological responses (Table 3).
Similarly, Capparucci et al., (2022) [123] evaluated the essential oil of basil (Ocimum basilicum), mainly constituted by linalool, eugenol, geraniol, citronellol and limonene, and reported that, in addition to producing anesthetic effects comparable to synthetic agents, these compounds only demonstrated significant adverse effects when higher concentrations were administered. In addition, this study also demonstrated antioxidant and cytoprotective properties with potential to reduce stress-related oxidative damage. Vieira et al., (2025) [124] investigated thymol and menthol in 3 dpf zebrafish larvae, revealing behavioral and metabolic responses similar to conventional anesthetics, which supports their suitability as anesthetics for zebrafish larvae. Moreover, exposure to these monoterpenes also has a marked effect on other relevant parameters, such as reduced glucose and heart rate peaks [122]. Although studies on the effects of natural substances during early developmental stages are still limited, complementary studies in adult zebrafish have further established the potential of menthol and thymol as effective anesthetics [124]. These results, combined with similarities in chemical structure and mechanisms of action, suggest a broader anesthetic potential inherent to all monoterpenes that further reinforce their overall valuable role as natural alternatives for stress mitigation [136,149]. In addition, monoterpenes are often accompanied by a list of equally interesting biological properties. In addition to improving zebrafish appetite, development and growth [124,150], monoterpenes also exhibit antioxidant, anti-inflammatory and anti-apoptotic effects [151,152,153] that make them particularly relevant for application during fish procedures and in experimental contexts [84,124,153].
Collectively, these findings highlight the potential of herbal anesthetics to serve as effective and less harmful substitutes for conventional compounds. Moreover, their use aligns with the 3Rs principle, promoting welfare-oriented practices and encouraging broader application in larval stages. Nevertheless, studies on their concentrations, pharmacokinetics, and long-term safety in early developmental stages remain scarce, reinforcing the need for further research to standardize and regulate the use of these alternatives in fish procedures and experimental settings [46,90]. Moreover, the potential effects associated with their application remain poorly described in zebrafish larvae. In other fish species, monoterpene exposure has been associated with cardiovascular and haemato-biochemical alterations that typically return to baseline during recovery, minimal changes in behavior, and reduced cellular stress markers [90]. While these findings may be applicable to zebrafish, this area is still in need of further investigation.

5. Limitations and Future Directions

Despite growing interest in plant-based anesthetics, some important limitations and challenges remain. The lack of standardized protocols for concentration, duration of exposure, and recovery assessment constitutes one of the most important limitations of using monoterpenes as anesthetic in zebrafish larvae, complicating cross-study comparison, regulatory approval, and implementation in routine practices [123,124]. Environmental factors, such as temperature, pH, and water salinity, can influence the efficacy of natural anesthetics, yet few studies systematically address these interactions [154,155,156,157]. Moreover, data on short-term exposures, long-term safety, potential bioaccumulation, and metabolization of monoterpenes are also largely underexplored, underscoring the need for harmonized methodologies and integrated biochemical and molecular analyses.
Research on monoterpenes in the early stages of development is still lacking. Yet studies on juvenile and adults show that essential oils and some isolated monoterpenes may cause dose-dependent toxicity, neurotoxicity, developmental problems, pro-oxidant activity and apoptosis when applied outside of the anesthesia area [32,33]. In addition, knowledge of the mechanisms of action of monoterpenes, particularly concerning receptor-level interactions and potential sensitivity across developmental stages, requires further clarification.
Due to their composition, essential oils may be associated with limitations related to solubility, which may subsequently interfere with the mechanisms of action [154,155,156,157]. The vast majority of essential oils have lipophilic properties which contribute to a rapid dispersion across biological membranes, including the blood–brain barrier, allowing for modulation of the CNS [37,158]. However, these substances also have hydrophobic characteristics that can alter their bioavailability and stability, potentially reducing efficacy. Encapsulating these compounds may help with absorption and improve passage into the bloodstream and through the blood–brain barrier, ultimately increasing bioavailability in the brain and ensuring the intended mechanisms of action [37,93,159]. Although there are works conducted in the adult zebrafish model on this topic [139,160], information on this process using zebrafish larvae is still lacking.

6. Conclusions

Natural monoterpenes have shown significant promise as sustainable anesthetic alternatives in aquaculture, as evidenced by their ability to modulate stress associated with handling and transporting in zebrafish larvae. Although standardization and long-term safety assessments are still required, these compounds may provide a promising route towards more ethical and environmentally responsible aquaculture practices. Overall, increasing the implementation of natural anesthetics into aquaculture represents a favorable shift toward systems that balance productivity with welfare and sustainability. Moreover, by combining pharmacological efficacy, biological safety, and ecological compatibility, monoterpenes provide a scientifically grounded, welfare-enhancing alternative that supports the evolution of responsible aquaculture.

Author Contributions

Conceptualization, C.A.S.V. and L.M.F.; methodology, R.S.F.V., C.A.S.V. and L.M.F.; formal analysis, R.S.F.V.; investigation, R.S.F.V.; resources, C.A.S.V. and L.M.F.; data curation, R.S.F.V.; writing—original draft preparation, R.S.F.V. and C.A.R.; writing—review and editing, R.S.F.V. and C.A.R., C.A.S.V. and L.M.F.; visualization, R.S.F.V.; supervision, C.A.S.V. and L.M.F.; project administration, C.A.S.V. and L.M.F.; funding acquisition, C.A.S.V. and L.M.F. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by National Funds by FCT—Portuguese Foundation for Science and Technology, under the projects UID/04033/2025: Centre for the Research and Technology of Agro-Environmental and Biological Sciences (https://doi.org/10.54499/UID/04033/2025) and LA/P/0126/2020 (https://doi.org/10.54499/LA/P/0126/2020). Luís Félix is thankful for his Junior Researcher contract (2021.00458.CEECIND) financed by FCT/MCTES.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data will be provided by the authors upon request.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
MS-222Tricaine methanesulfonate
HPIHypothalamus–pituitary–interrenal
HPAHypothalamus–pituitary–adrenal
CNS Central nervous system
CRHCorticotropin-releasing hormone
ACTHAdrenocorticotropic hormone
BSCBrain–sympathetic–chromaffin
ANITEuropean Parliament’s Committee of Inquiry on the Protection of Animals during Transport
WOAHWorld Organization for Animal Health
hpfHours post-fertilization
GCGlucocorticoid
MRMineralocorticoid receptor
GSTGlutathione s-transferase
dpfDays post-fertilization
GABAGamma-aminobutyric acid
NMDAN-methyl-D-aspartate
TRPV-1Transient receptor potential vanilloid-1

References

  1. Bonga, S.E.W. The stress response in fish. Physiol. Rev. 1997, 77, 591–625. [Google Scholar] [CrossRef]
  2. Barton, B.A. Stress in fishes: A diversity of responses with particular reference to changes in circulating corticosteroids. Integr. Comp. Biol. 2002, 42, 517–525. [Google Scholar] [CrossRef]
  3. Gorissen, M.; Flik, G. The Endocrinology of the Stress Response in Fish, in Biology of Stress in Fish. In Fish Physiology; Schreck, C.B., Tort, L., Farrell, A.P., Brauner, C.J., Eds.; Academic Press: Amsterdam, The Netherlands, 2016; pp. 75–111. [Google Scholar]
  4. Flik, G.; Klaren, P.H.M.; van den Burg, E.H.; Metz, J.R.; Huising, M.O. CRF and stress in fish. Gen. Comp. Endocrinol. 2006, 146, 36–44. [Google Scholar] [CrossRef] [PubMed]
  5. Huising, M.O.; Flik, G. The remarkable conservation of corticotropin-releasing hormone-binding protein in the stress axis of vertebrates. Gen. Comp. Endocrinol. 2005, 144, 104–113. [Google Scholar]
  6. Alsop, D.; Vijayan, M.M. Development of the corticosteroid stress axis and receptor expression in zebrafish. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 294, R711–R719. [Google Scholar] [CrossRef] [PubMed]
  7. Mommsen, T.P.; Vijayan, M.M.; Moon, T.W. Cortisol in teleosts: Dynamics, mechanisms of action, and metabolic regulation. Rev. Fish Biol. Fish. 1999, 9, 211–268. [Google Scholar] [CrossRef]
  8. Reid, S.G.; Bernier, N.J.; Perry, S.F. The adrenergic stress response in fish: Control of catecholamine storage and release. Comp. Biochem. Physiol. Part C 1998, 120, 1–27. [Google Scholar] [CrossRef]
  9. Sopinka, N.M.; Donaldson, M.R.; O’Connor, C.M.; Suski, C.D.; Cooke, S.J. Stress Indicators in Fish. In Biology of Stress in Fish: Fish Physiology; Schreck, C.B., Tort, L., Farrel, A.P., Brauner, C.J., Eds.; Elsevier: Amsterdam, The Netherlands, 2016; pp. 405–462. [Google Scholar] [CrossRef]
  10. Martínez-Porchas, M.; Martínez-Córdova, L.R.; Ramos-Enriquez, R. Cortisol and Glucose: Reliable indicators of fish stress? Pan-Am. J. Aquat. Sci. 2009, 4, 158–178. [Google Scholar]
  11. Mandelman, J.W.; Skomal, G.B. The physiological stress response in elasmobranch fishes: Selected papers from a symposium at the 26th annual meeting of the American Elasmobranch Society. Comp. Biochem. Physiol. Part A Mol. Integr. Physiol. 2012, 162, 71–72. [Google Scholar] [CrossRef]
  12. Rehman, S.; Gora, A.H.; Ahmad, I.; Rasool, S.I. Stress in Aquaculture Hatcheries: Source Impact and Mitigation. Int. J. Curr. Microbiol. Appl. Sci. 2017, 6, 3030–3045. [Google Scholar] [CrossRef]
  13. Ciji, A.; Akhtar, M.S. Stress management in aquaculture: A review of dietary interventions. Rev. Aquacult. 2021, 13, 2190–2247. [Google Scholar] [CrossRef]
  14. Varghese, T.; Ebeneeza, S.; Ahmad Dar, S.; Kumar Pal, A. Mitigation of stress in fish through nutraceuticals. World J. Aquac. Res. Dev. 2021, 3, 1014. [Google Scholar]
  15. Brandão, M.L.; Dorigao-Guimaraes, F.; Bolognesi, M.C.; Gauy, A.C.S.; Pereira, A.V.S.; Vian, L.; Carvalho, T.B.; Goncalves-de-Freitas, E. Understanding behaviour to improve the welfare of an ornamental fish. J. Fish Biol. 2021, 99, 726–739. [Google Scholar] [CrossRef]
  16. Valcarce, D.G.; Sellés-Egea, A.; Riesco, M.F.; De Garnica, M.G.; Martínez-Fernández, B.; Herráez, M.P.; Robles, V. Early stress exposure on zebrafish development: Effects on survival, malformations and molecular alterations. Fish Physiol. Biochem. 2024, 50, 1545–1562. [Google Scholar] [CrossRef]
  17. Best, C.; Kurrasch, D.M.; Vijayan, M.M. Maternal cortisol stimulates neurogenesis and affects larval behaviour in zebrafish. Sci. Rep. 2017, 7, 40905. [Google Scholar] [CrossRef]
  18. Higuchi, M. Maternal stress suppresses cell proliferation in the forebrain of zebrafish larvae. Genes Cells 2020, 25, 350–357. [Google Scholar] [CrossRef] [PubMed]
  19. Chin, J.S.R.; Phan, T.N.; Albert, L.T.; Keene, A.C.; Duboué, E.R. Long lasting anxiety following early life stress is dependent on glucocorticoid signaling in zebrafish. Sci. Rep. 2022, 12, 12826. [Google Scholar] [CrossRef] [PubMed]
  20. Fan, X.; Hou, T.; Sun, T.; Zhu, L.; Zhang, S.; Tang, K.; Wang, Z. Starvation stress affects the maternal development and larval fitness in zebrafish (Danio rerio). Sci. Tot. Environ. 2019, 695, 133897. [Google Scholar] [CrossRef]
  21. Ashley, P.J. Fish welfare: Current issues in aquaculture. Appl. Anim. Behav. Sci. 2007, 104, 199–235. [Google Scholar] [CrossRef]
  22. Gabriel, U.U.; Akinrotimi, O.A. Management of stress in fish for sustainable aquaculture development. Researcher 2011, 3, 28–38. [Google Scholar]
  23. Becker, A.G.; Cunha, M.A.; Garcia, L.O.; Zeppenfeld, C.C.; Parodi, T.V.; Maldaner, G.; Morel, A.F.; Baldisserotto, B. Efficacy of eugenol and the methanolic extract of Condalia buxifolia during the transport of the silver catfish Rhamdia quelen. Neotrop. Ichthyol. 2013, 11, 675–681. [Google Scholar] [CrossRef]
  24. Parodi, T.V.; Cunha, M.A.; Becker, A.G.; Zeppenfeld, C.C.; Martins, D.I.; Koakoski, G.; Barcellos, L.G.; Heinzmann, B.M.; Baldisserotto, B. Anesthetic activity of the essential oil of Aloysia triphylla and effectiveness in reducing stress during transport of albino and gray strains of silver catfish, Rhamdia quelen. Fish. Physiol. Biochem. 2014, 40, 323–334. [Google Scholar] [CrossRef]
  25. Teixeira, R.R.; Souza, R.; Sena, A.C.; Baldisserotto, B.; Heinzmann, B.M.; Copatti, C.E. Essential oil of Aloysia triphylla is effective in Nile tilapia transport. Bol. Inst. Pesca 2018, 44, 17–24. [Google Scholar] [CrossRef]
  26. Lim, L.C.; Dhert, P.; Sorgeloos, P. Recent developments and improvements in ornamental fish packaging systems for air transport. Aquacult. Res. 2003, 34, 923–935. [Google Scholar] [CrossRef]
  27. Luz, R.K.; Favero, G.C. Use of Salt, Anesthetics, and Stocking Density in Transport of Live Fish: A Review. Fishes 2024, 9, 286. [Google Scholar] [CrossRef]
  28. Sherif, A.H.; Eldessouki, E.A.; Sabry, N.M.; Ali, N.G. The protective role of iodine and MS-222 against stress response and bacterial infections during Nile tilapia (Oreochromis niloticus) transportation. Aquacult. Int. 2023, 31, 401–416. [Google Scholar] [CrossRef]
  29. Zhang, H.; Wang, Q.; Dong, Y.; Mei, J.; Xie, J. Effects of tricaine methanesulphonate (MS-222) on physiological stress and fresh quality of sea bass (Lateolabrax maculatus) under simulated high-density and long-distance transport stress. Biology 2023, 12, 223. [Google Scholar] [CrossRef] [PubMed]
  30. Bortoletti, M.; Fonsatti, E.; Leva, F.; Maccatrozzo, L.; Ballarin, C.; Radaelli, G.; Caberlotto, S.; Bertotto, D. Influence of Transportation on Stress Response and Cellular Oxidative Stress Markers in Juvenile Meagre (Argyrosomus regius). Animals 2023, 13, 3288. [Google Scholar] [CrossRef] [PubMed]
  31. Brandão, F.R.; Duncan, W.P.; Farias, C.F.S.; de Melo Souza, D.C.; de Oliveira, M.I.B.; Rocha, M.J.S.; Monteiro, P.C.; Majolo, C.; Chaves, F.C.M.; de Almeida O’Sullivan, F.L. Essential oils of Lippia sidoides and Mentha piperita as reducers of stress during the transport of Colossoma macropomum. Aquaculture 2022, 560, 738515. [Google Scholar] [CrossRef]
  32. Becker, A.G.; Parodi, T.V.; Heldwein, C.G.; Zeppenfeld, C.C.; Heinzmann, B.M.; Baldisserotto, B. Transportation of silver catfish, Rhamdia quelen, in water with eugenol and the essential oil of Lippia alba. Fish Physiol. Biochem. 2012, 38, 789–796. [Google Scholar] [CrossRef]
  33. Harmon, T.S. Methods for reducing stressors and maintaining water quality associated with live fish transport in tanks: A review of the basics. Rev. Aquacult. 2009, 1, 58–66. [Google Scholar] [CrossRef]
  34. Zeppenfeld, C.C.; Toni, C.; Becker, A.G.; Miron, D.D.; Parodi, T.V.; Heinzmann, B.M.; Barcellos, L.J.G.; Koakoski, G.; da Rosa, J.G.S.; Loro, V.L.; et al. Physiological and biochemical responses of silver catfish, Rhamdia quelen, after transport in water with essential oil of Aloysia triphylla (L’Herit) Britton. Aquaculture 2014, 418, 101–107. [Google Scholar] [CrossRef]
  35. Lemos, L.S.; Angarica, L.M.; Hauser-Davis, R.A.; Quinete, N. Cortisol as a Stress Indicator in Fish: Sampling Methods Analytical Techniques Organic Pollutant Exposure Assessments. Int. J. Environ. Res. Public Health 2023, 20, 6237. [Google Scholar] [CrossRef]
  36. Gomes, L.C.; Chagas, E.C.; Brinn, R.P.; Roubach, R.; Coppati, C.E.; Baldisserotto, B. Use of salt during transportation of air breathing pirarucu juveniles (Arapaima gigas) in plastic bags. Aquaculture 2006, 256, 521–528. [Google Scholar] [CrossRef]
  37. Souza, C.F.; Baldissera, M.D.; Baldisserotto, B.; Heinzmann, B.M.; Martos-Sitcha, J.A.; Mancera, J.M. Essential Oils as Stress-Reducing Agents for Fish Aquaculture: A Review. Front. Physiol. 2019, 10, 785. [Google Scholar] [CrossRef] [PubMed]
  38. Mu, X.; Pang, S.; Sun, X.; Gao, J.; Chen, J.; Chen, X.; Li, X.; Wang, C. Evaluation of acute and developmental effects of difenoconazole via multiple stage zebrafish assays. Environ. Pollut. 2013, 175, 147–157. [Google Scholar] [CrossRef] [PubMed]
  39. Evers, H.-G.; Pinnegar, J.K.; Taylor, M.I. Where are they all from?—Sources sustainability in the ornamental freshwater fish trade. J. Fish. Biol. 2019, 94, 909–916. [Google Scholar] [CrossRef] [PubMed]
  40. Browning, H. Improving welfare assessment in aquaculture. Front. Vet. Sci. 2023, 10, 1060720. [Google Scholar] [CrossRef]
  41. Mancuso, M. Fish welfare in aquaculture. J. Aquacult. Res. Dev. 2013, 4, e107. [Google Scholar] [CrossRef]
  42. Toni, M.; Manciocco, A.; Angiulli, E.; Alleva, E.; Cioni, C.; Malavasi, S. Review: Assessing fish welfare in research and aquaculture, with a focus on European directives. Animal 2019, 13, 161–170. [Google Scholar] [CrossRef]
  43. Martos-Sitcha, J.A.; Mancera, J.M.; Prunet, P.; Magnoni, L.J. Editorial: Welfare and Stressors in Fish: Challenges Facing Aquaculture. Front. Physiol. 2020, 11, 162. [Google Scholar] [CrossRef]
  44. Ciliberti, R.; Alfano, L.; Petralia, P. Ethics in aquaculture: Animal welfare environmental sustainability. J. Prev. Med. Hyg. 2023, 64, e443–e447. [Google Scholar] [CrossRef]
  45. Stevens, C.H.; Croft, D.P.; Paull, G.C.; Tyler, C.R. Stress welfare in ornamental fishes: What can be learned from aquaculture? J. Fish Biol. 2017, 91, 409–428. [Google Scholar] [CrossRef]
  46. Minaz, M.; Félix, L. Trends and advancements in fish anaesthesia over the last decade. Aquaculture 2026, 612, 743147. [Google Scholar] [CrossRef]
  47. Eachus, H.; Choi, M.K.; Ryu, S. The Effects of Early Life Stress on the Brain and Behaviour: Insights From Zebrafish Models. Front. Cell Dev. Biol. 2021, 9, 657591. [Google Scholar] [CrossRef]
  48. Felix, L.; Coimbra, A.M.; Valentim, A.M.; Antunes, L. Review on the use of zebrafish embryos to study the effects of anesthetics during early development. Crit. Rev. Toxicol. 2019, 49, 357–370. [Google Scholar] [CrossRef]
  49. Jørgensen, L.V.G. Zebrafish as a Model for Fish Diseases in Aquaculture. Pathogens 2020, 9, 609. [Google Scholar] [CrossRef] [PubMed]
  50. Ulloa, P.E.; Medrano, J.F.; Feijoo, C.G. Zebrafish as animal model for aquaculture nutrition research. Front. Genet. 2014, 5, 313. [Google Scholar] [CrossRef] [PubMed]
  51. Strahle, U.; Scholz, S.; Geisler, R.; Greiner, P.; Hollert, H.; Rastegar, S.; Schumacher, A.; Selderslaghs, I.; Weiss, C.; Witters, H.; et al. Zebrafish embryos as an alternative to animal experiments-a commentary on the definition of the onset of protected life stages in animal welfare regulations. Reprod. Toxicol. 2012, 33, 128–132. [Google Scholar] [CrossRef]
  52. Rico, E.P.; Rosemberg, D.B.; Seibt, K.J.; Capiotti, K.M.; Da Silva, R.S.; Bonan, C.D. Zebrafish neurotransmitter systems as potential pharmacological and toxicological targets. Neurotoxicol. Teratol. 2011, 33, 608–617. [Google Scholar] [CrossRef]
  53. Ribas, L.; Piferrer, F. The zebrafish (Danio rerio) as a model organism, with emphasis on applications for finfish aquaculture research. Rev. Aquacult. 2014, 6, 209–240. [Google Scholar] [CrossRef]
  54. Zon, L.I.; Peterson, R.T. In vivo drug discovery in the zebrafish. Nat. Rev. Drug Discov. 2005, 4, 35–44. [Google Scholar] [CrossRef]
  55. McGrath, P.; Li, C.Q. Zebrafish: A predictive model for assessing drug-induced toxicity. Drug Discov. Today 2008, 13, 394–401. [Google Scholar] [CrossRef]
  56. Vieira, R.; Venâncio, C.A.S.; Félix, L.M. Toxic effects of a mancozeb-containing commercial formulation at environmental relevant concentrations on zebrafish embryonic development. Environ. Sci. Pollut. Res. Int. 2020, 27, 21174–21187. [Google Scholar] [CrossRef] [PubMed]
  57. Lee-Estevez, M.; Figueroa, E.; Cosson, J.; Short, S.E.; Valdebenito, I.; Ulloa-Rodríguez, P.; Farías, J.G. Zebrafish as a useful model for immunological research with potential applications in aquaculture. Rev. Aquacult. 2018, 10, 213–223. [Google Scholar] [CrossRef]
  58. Dahm, R.; Geisler, R. Learning from small fry: The zebrafish as a genetic model organism for aquaculture fish species. Mar. Biotechnol. 2006, 8, 329–345. [Google Scholar] [CrossRef] [PubMed]
  59. Schroeder, P.G. The welfare of zebrafish. In Laboratory Fish in Biomedical Research; D’Angelo, L., de Girolamo, P., Eds.; Academic Press: Amsterdam, The Netherlands, 2022; pp. 101–117. [Google Scholar] [CrossRef]
  60. Steenbergen, P.J.; Richardson, M.K.; Champagne, D.L. The use of the zebrafish model in stress research. Prog. Neuro-psychopharmacol. Biol. Psychiatry 2011, 35, 1432–1451. [Google Scholar] [CrossRef]
  61. Piferrer, F.; Ribas, L. The use of the zebrafish as a model in fish aquaculture research. In Fish Physiology; Benfey, T.J., Farrell, A.P., Brauner, C.J., Eds.; Academic Press: Amsterdam, The Netherlands, 2020; pp. 273–313. [Google Scholar] [CrossRef]
  62. Spagnoli, S.; Lawrence, C.; Kent, M.L. Stress in Fish as Model Organisms. In Fish Physiology; Schreck, C.B., Tort, L., Farrell, A.P., Brauner, C.J., Eds.; Academic Press: Amsterdam, The Netherlands, 2016; pp. 541–564. [Google Scholar] [CrossRef]
  63. Rosa, J.G.S.; Lima, C.; Lopes-Ferreira, M. Zebrafish Larvae Behavior Models as a Tool for Drug Screenings Pre-Clinical Trials: A Review. Int. J. Molec. Sci. 2022, 23, 6647. [Google Scholar] [CrossRef]
  64. Basnet, R.M.; Zizioli, D.; Taweedet, S.; Finazzi, D.; Memo, M. Zebrafish Larvae as a Behavioral Model in Neuropharmacology. Biomedicines 2019, 7, 23. [Google Scholar] [CrossRef]
  65. de Marco, R.J. The Potential of Zebrafish Larvae and Water Vortex Protocols in Stress Biology. Endocrines 2025, 6, 11. [Google Scholar] [CrossRef]
  66. Faught, E.; Vijayan, M.M. The mineralocorticoid receptor is essential for stress axis regulation in zebrafish larvae. Sci. Rep. 2018, 8, 18081. [Google Scholar] [CrossRef]
  67. Rudneva, I. Biomarkers for Stress in Fish Embryos and Larvae, 1st ed.; CRC Press: Boca Raton, FL. USA, 2014; pp. 1–15. [Google Scholar] [CrossRef]
  68. Pietsch, C.; Konrad, J.; Pawlak, P. Acute Stress Effects over Time on Gene Expression Patterns in the Male Zebrafish (Danio rerio) Brain. Animals 2025, 15, 2431. [Google Scholar] [CrossRef]
  69. Li, X.; Fu, C.; Tan, X.; Fu, S. Responses of zebrafish to chronic environmental stressors: Anxiety-like behavior and its persistence. Front. Mar. Sci. 2025, 12, 1551595. [Google Scholar] [CrossRef]
  70. Alsop, D.; Vijayan, M.M. Molecular programming of the corticosteroid stress axis during zebrafish development. Comp. Biochem. Physiol. Part A Molec. Integr. Physiol. 2009, 153, 49–54. [Google Scholar] [CrossRef] [PubMed]
  71. Faught, E.; Vijayan, M.M. Coordinated Action of Corticotropin-Releasing Hormone and Cortisol Shapes the Acute Stress-Induced Behavioural Response in Zebrafish. Neuroendocrinol 2022, 112, 74–87. [Google Scholar] [CrossRef]
  72. Castillo-Ramírez, L.A.; Ryu, S.; de Marco, R.J. Active behaviour during early development shapes glucocorticoid reactivity. Sci. Rep. 2019, 9, 12796. [Google Scholar] [CrossRef] [PubMed]
  73. Castillo-Ramirez, L.A.; Ryu, S.; de Marco, R.J. Cortisol dynamics and GR-dependent feedback regulation in zebrafish larvae exposed to repeated stress. Biol. Open 2024, 13, bio061683. [Google Scholar] [CrossRef] [PubMed]
  74. Vieira, R.S.F.; Venâncio, C.A.S.; Félix, L.M. Behavioral, metabolic, and biochemical alterations caused by an acute stress event in a zebrafish larvae model. Fish. Physiol. Biochem. 2025, 51, 25. [Google Scholar] [CrossRef]
  75. Eissa, N.; Wang, H.-P. Transcriptional stress responses to environmental and husbandry stressors in aquaculture species. Rev. Aquacult. 2016, 8, 61–88. [Google Scholar] [CrossRef]
  76. Ehrlich, O.; Karamalakis, A.; Krylov, A.J.; Dudczig, S.; Hassell, K.L.; Jusuf, P.R. Clove Oil and AQUI-S Efficacy for Zebrafish Embryo, Larva, and Adult Anesthesia. Zebrafish 2019, 16, 451–459. [Google Scholar] [CrossRef]
  77. Félix, L.; Campos, S.; Guedes de Pinho, P.; Antunes, L.; Valentim, A.M. Early developmental effects of propofol exposure in different stages of zebrafish embryos. Toxicol. Lett. 2025, 403, 84–93. [Google Scholar] [CrossRef]
  78. Eto, K.; Mazilu-Brown, J.K.; Henderson-MacLennan, N.; Dipple, K.M.; McCabe, E.R.B. Development of catecholamine and cortisol stress responses in zebrafish. Molec. Genet. Metabol. Rep. 2014, 1, 373–377. [Google Scholar] [CrossRef]
  79. de Abreu, M.S.; Demin, K.A.; Giacomini, A.; Amstislavskaya, T.G.; Strekalova, T.; Maslov, G.O.; Kositsin, Y.; Petersen, E.V.; Kalueff, A.V. Understanding how stress responses and stress-related behaviors have evolved in zebrafish and mammals. Neurobiol. Stress 2021, 15, 100405. [Google Scholar] [CrossRef] [PubMed]
  80. Rombough, P. The energetics of embryonic growth. Respir. Physiol. Neurobiol. 2011, 178, 22–29. [Google Scholar] [CrossRef] [PubMed]
  81. Rombough, P.J. Ontogenetic changes in the toxicity and efficacy of the anaesthetic MS222 (tricaine methanesulfonate) in zebrafish (Danio rerio) larvae. Comp. Biochem. Physiol. Part. A Mol. Integr. Physiol. 2007, 148, 463–469. [Google Scholar] [CrossRef]
  82. Bedell, V.; Buglo, E.; Marcato, D.; Pylatiuk, C.; Mikut, R.; Stegmaier, J.; Scudder, W.; Wray, M.; Züchner, S.; Strähle, U. Zebrafish: A pharmacogenetic model for anesthesia. Methods Enzymol. 2018, 602, 189–209. [Google Scholar] [CrossRef] [PubMed]
  83. Felix, L.M.; Luzio, A.; Themudo, M.; Antunes, L.; Matos, M.; Coimbra, A.M.; Valentim, A.M. MS-222 short exposure induces developmental and behavioural alterations in zebrafish embryos. Reprod. Toxicol. 2018, 81, 122–131. [Google Scholar] [CrossRef]
  84. Rocha, C.A.; Félix, L.M.; Monteiro, S.M.; Venâncio, C.A. Antinociceptive Analysis of Natural Monoterpenes Eugenol, Menthol, Carvacrol and Thymol in a Zebrafish Larval Model. Pharmaceuticals 2024, 17, 457. [Google Scholar] [CrossRef]
  85. Tao, Y.; Du, C.; Duan, B.; Wang, W.; Guo, H.; Feng, J.; Xu, H.; Li, Y. Eugenol exposure inhibits embryonic development and swim bladder formation in zebrafish. Comp. Biochem. Physiol. Part C Toxicol. Pharmacol. 2023, 268, 109602. [Google Scholar] [CrossRef]
  86. Rocha, C.A.; Félix, L.M.; Monteiro, S.M.; Venâncio, C.A. Advancing Zebrafish (Danio rerio) Welfare Using Immersion Analgesics. Vet. Sci. 2025, 12, 571. [Google Scholar] [CrossRef]
  87. Köhler, A.; Valentim, A.M. Analgesia, anesthesia, and euthanasia in zebrafish. In Laboratory Fish in Biomedical Research; D’Angelo, L., de Girolamo, P., Eds.; Academic Press: Amsterdam, The Netherlands, 2022; pp. 119–137. [Google Scholar] [CrossRef]
  88. Matthews, M.; Varga, Z.M. Anesthesia and euthanasia in zebrafish. ILAR J. 2012, 53, 192–204. [Google Scholar] [CrossRef] [PubMed]
  89. Schnick, R.R. Zero withdrawal anesthetic for all finfish and shellfish: Need and candidates. Fisheries 2006, 31, 122–126. [Google Scholar] [CrossRef]
  90. Félix, L.; Vieira, R.; Monteiro, S.M.; Venâncio, C. A meta-analytic review of monoterpene for fish anaesthesia. Fish Fish. 2023, 24, 367–380. [Google Scholar] [CrossRef]
  91. Schroeder, P.; Lloyd, R.; McKimm, R.; Metselaar, M.; Navarro, J.; O’Farrell, M.; Readman, G.D.; Speilberg, L.; Mocho, J.P. Anaesthesia of laboratory, aquaculture and ornamental fish: Proceedings of the first LASA-FVS Symposium. Lab. Anim. 2021, 55, 317–328. [Google Scholar] [CrossRef]
  92. Ross, L.G.; Ross, B.R. The Nature of Anaesthesia, Sedation and Analgesia. In Anaesthetic and Sedative Techniques for Aquatic Animals; Ross, L.G., Ross, B.R., Eds.; Wiley-Blackwell: Hoboken, NJ, USA, 2008; pp. 41–51. [Google Scholar] [CrossRef]
  93. Zahl, I.H.; Samuelsen, O.; Kiessling, A. Anaesthesia of farmed fish: Implications for welfare. Fish. Physiol. Biochem. 2012, 38, 201–218. [Google Scholar] [CrossRef] [PubMed]
  94. Ross, L.G.; Ross, B.R. The Features of Anaesthetic Agents. In Anaesthetic and Sedative Techniques for Aquatic Animals; Ross, L.G., Ross, B.R., Eds.; Wiley-Blackwell: Hoboken, NJ, USA, 2008; pp. 53–56. [Google Scholar] [CrossRef]
  95. Marking, L.L.; Meyer, F.P. Are Better Anesthetics Needed in Fisheries? Fisheries 1985, 10, 2–5. [Google Scholar] [CrossRef]
  96. Wedemeyer, G. Effects of Fish Cultural Procedures. In Physiology of fish in intensive culture systems, 1st ed.; Springer: Berlin, Germany, 1996; pp. 111–165. [Google Scholar] [CrossRef]
  97. Flecknell, P. Basic Principles of Anaesthesia. In Laboratory Animal Anaesthesia; Academic Press: Amsterdam, The Netherlands, 2015; pp. 1–75. [Google Scholar] [CrossRef]
  98. Coyle, S.D.; Durborow, R.M.; Tidwell, J.H. Anesthetics in Aquaculture: Publication No. 3900; Southern Regional Aquaculture Center: Stoneville, MS, USA, 2004. [Google Scholar]
  99. Purbosari, N.; Warsiki, E.; Syamsu, K.; Santoso, J. Natural versus synthetic anesthetic for transport of live fish: A review. Aquacult. Fish. 2019, 4, 129–133. [Google Scholar] [CrossRef]
  100. Neiffer, D.L.; Stamper, M.A. Fish sedation, anesthesia, analgesia, and euthanasia: Considerations, methods, and types of drugs. ILAR J. 2009, 50, 343–360. [Google Scholar] [CrossRef]
  101. Priborsky, J.; Velisek, J. A Review of Three Commonly Used Fish Anesthetics. Rev. Fish. Sci. Aquacult. 2018, 26, 417–442. [Google Scholar] [CrossRef]
  102. Sneddon, L.U. Clinical Anesthesia Analgesia in Fish. J. Exot. Pet. Med. 2012, 21, 32–43. [Google Scholar] [CrossRef]
  103. Dimitriadou, S.; Miller, M.; Pilehvar, A.; Sneddon, L.U.; Bamsey, J.L.; Hogan-Bassey, D.; Trznadel, M.; Ball, J.S.; Takesono, A.; Hillman, C.; et al. Evaluating anaesthetics for improving science and welfare using larval zebrafish. bioRxiv 2025, preprint. [Google Scholar] [CrossRef]
  104. Leyden, C.; Brüggemann, T.; Debinski, F.; Simacek, C.A.; Dehmelt, F.A.; Arrenberg, A.B. Efficacy of Tricaine (MS-222) and Hypothermia as Anesthetic Agents for Blocking Sensorimotor Responses in Larval Zebrafish. Front. Vet. Sci. 2022, 9, 864573. [Google Scholar] [CrossRef] [PubMed]
  105. Ge, Y.; Yuan, W.; Jia, W.; Guan, Z.; Huang, T.; Zhang, Y.; Song, C.; Xiao, Y.; Gao, J. Apoptotic mechanism of propofol-induced developmental toxicity in zebrafish embryos. PLoS ONE 2023, 18, e0286391. [Google Scholar] [CrossRef] [PubMed]
  106. Neiffer, D.L. Anesthesia and analgesia. In Clinical Guide to Fish Medicine; Hadfield, C.A., Clayton, L.A., Eds.; Wiley-Blackwell: Hoboken, NJ, USA, 2021; pp. 198–212. [Google Scholar] [CrossRef]
  107. Chen, K.; Wang, C.Q.; Fan, Y.Q.; Xie, Y.S.; Yin, Z.F.; Xu, Z.J.; Zhang, H.L.; Cao, J.T.; Han, Z.H.; Wang, Y.; et al. The evaluation of rapid cooling as an anesthetic method for the zebrafish. Zebrafish 2014, 11, 71–75. [Google Scholar] [CrossRef]
  108. Massee, K.C.; Rust, M.B.; Hardy, R.W.; Stickney, R.R. The effectiveness of tricaine, quinaldine sulfate and metomidate as anesthetics for larval fish. Aquaculture 1995, 134, 351–359. [Google Scholar] [CrossRef]
  109. Felix, L.M.; Luzio, A.; Antunes, L.; Coimbra, A.M.; Valentim, A.M. Malformations and mortality in zebrafish early stages associated with elevated caspase activity after 24 h exposure to MS-222. Toxicol. Appl. Pharmacol. 2021, 412, 115385. [Google Scholar] [CrossRef]
  110. Felix, L.M.; Luzio, A.; Santos, A.; Antunes, L.M.; Coimbra, A.M.; Valentim, A.M. MS-222 induces biochemical and transcriptional changes related to oxidative stress, cell proliferation and apoptosis in zebrafish embryos. Comp. Biochem. Physiol. Part C Toxicol. Pharmacol. 2020, 237, 108834. [Google Scholar] [CrossRef]
  111. Guo, P.; Huang, Z.; Tao, T.; Chen, X.; Zhang, W.; Zhang, Y.; Lin, C. Zebrafish as a model for studying the developmental neurotoxicity of propofol. J. Appl. Toxicol. 2015, 35, 1511–1519. [Google Scholar] [CrossRef]
  112. Qian, S.; Liu, H.; Wei, H.; Liu, J.; Li, X.; Luo, X. Toxic effects of prolonged propofol exposure on cardiac development in zebrafish larvae. BMC Anesthesiol. 2025, 25, 81. [Google Scholar] [CrossRef]
  113. Luo, X.; Chen, L.; Zhang, Y.; Liu, J.; Xie, H. Developmental and cardiac toxicities of propofol in zebrafish larvae. Comp. Biochem. Physiol. Part C Toxicol. Pharmacol. 2020, 237, 108838. [Google Scholar] [CrossRef]
  114. Mocho, J.P.; Lang, F.; Valentin, G.; Bedu, S.; McKimm, R.; Ramos, J.; Saavedra Torres, Y.; Wheatley, S.E.; Higgins, J.; Millington, M.E.; et al. A Multi-Site Assessment of Anesthetic Overdose, Hypothermic Shock, and Electrical Stunning as Methods of Euthanasia for Zebrafish (Danio rerio) Embryos and Larvae. Biology 2022, 11, 546. [Google Scholar] [CrossRef]
  115. Emeka, U.; Iloegbunam, N.G.; Gbekele-Oluwa, A.R. Natural Products and Aquaculture Development. IOSR J. Pharm. Biol. Sci. 2014, 9, 70–82. [Google Scholar] [CrossRef]
  116. Junior, E.F.d.M.; Uehara, S.A.; Rodrigues, E.C.; Palheta, G.D.A.; Melo NFACd Freire, L.d.S.; Takata, R. Menthol and eugenol as natural anesthetics for early juveniles of curimba. Rev. Bras. Zootec. 2018, 47, e20170266. [Google Scholar] [CrossRef]
  117. Abbaszadeh, S.; Sharifzadeh, A.; Shokri, H.; Khosravi, A.R.; Abbaszadeh, A. Antifungal efficacy of thymol carvacrol eugenol menthol as alternative agents to control the growth of food-relevant fungi. J. Mycol. Med. 2014, 24, e51–e56. [Google Scholar] [CrossRef]
  118. Khalil, A.A.; ur Rahman, U.; Khan, M.R.; Sahar, A.; Mehmood, T.; Khan, M. Essential oil eugenol: Sources, extraction techniques and nutraceutical perspectives. RSC Adv. 2017, 7, 32669–32681. [Google Scholar] [CrossRef]
  119. Kheawfu, K.; Pikulkaew, S.; Hamamoto, H.; Sekimizu, K.; Okonogi, S. Influence of clove oil and eugenol on muscle contraction of silkworm (Bombyx mori). Drug Discov. Ther. 2017, 11, 64–69. [Google Scholar] [CrossRef] [PubMed]
  120. Barbas, L.A.L.; Torres, M.F.; Da Costa, B.M.P.; Feitosa, M.J.M.; Maltez, L.C.; Amado, L.L.; Toda, Y.P.S.; Batista, P.D.S.; Cabral, D.A.C.; Hamoy, M. Eugenol induces body immobilization yet evoking an increased neuronal excitability in fish during short-term baths. Aquat. Toxicol. 2021, 231, 105734. [Google Scholar] [CrossRef]
  121. Pramod, K.; Ansari, S.H.; Ali, J. Eugenol: A natural compound with versatile pharmacological actions. Nat. Prod. Commun. 2010, 5, 1999–2006. [Google Scholar] [CrossRef]
  122. Vieira, R.S.F.; Sousa, D.; Félix, L.M.; Venâncio, C.A.S. Anaesthetic profile of thymol and menthol in zebrafish larvae model. Aquacult. Fish. 2025, 10, 401–410. [Google Scholar] [CrossRef]
  123. Capparucci, F.; De Benedetto, G.; Natale, S.; Pecoraro, R.; Iaria, C.; Marino, F. Evaluation of Anaesthetic Effect of Commercial Basil Ocimum basilicum on Zebrafish (Danio rerio) Embryos. Fishes 2022, 7, 318. [Google Scholar] [CrossRef]
  124. Vieira, R.S.F.; Venancio, C.A.S.; Felix, L.M. Thymol and menthol as anaesthetics for short transportation of zebrafish larva. Fish Physiol. Biochem. 2025, 51, 129. [Google Scholar] [CrossRef]
  125. Bianchini, A.E.; Garlet, Q.I.; da Cunha, J.A.; Bandeira, G.J.; Brusque, I.C.M.; Salbego, J.; Heinzmann, B.M.; Baldisserotto, B. Monoterpenoids (thymol carvacrol S-(+)-linalool) with anesthetic activity in silver catfish (Rhamdia quelen): Evaluation of acetylcholinesterase GABAergic activity Braz. J. Med. Biol. Res. 2017, 50, e6346. [Google Scholar] [CrossRef]
  126. Ghelardini, C.; Galeotti, N.; Mazzanti, G. Local Anaesthetic Activity of Monoterpenes and Phenylpropanes of Essential Oils. Planta Med. 2001, 67, 564–566. [Google Scholar] [CrossRef]
  127. Koziol, A.; Stryjewska, A.; Librowski, T.; Salat, K.; Gawel, M.; Moniczewski, A.; Lochynski, S. An overview of the pharmacological properties and potential applications of natural monoterpenes. Mini Rev. Med. Chem. 2014, 14, 1156–1168. [Google Scholar] [CrossRef]
  128. Loza-Tavera, H. Monoterpenes in Essential Oils. In Chemicals via Higher Plant Bioengineering; Shahidi, F., Kolodziejczyk, P., Whitaker, J.R., Munguia, A.L., Fuller, G., Eds.; Springer: Berlin, Germany, 1999; pp. 49–62. [Google Scholar] [CrossRef]
  129. Zielińska-Błajet, M.; Feder-Kubis, J. Monoterpenes Their Derivatives—Recent Development in Biological Medical Applications. Int. J. Molec. Sci. 2020, 21, 7078. [Google Scholar] [CrossRef] [PubMed]
  130. Umaru, I.J. Introduction to natural product. In Extraction of Natural Products from Agro-Industrial Wastes; Bhawani, S.A., Khan, A., Ahmad, F.B., Eds.; Elsevier: Amsterdam, The Netherlands, 2023; pp. 19–34. [Google Scholar] [CrossRef]
  131. Menzikov, S.A.; Zaichenko, D.M.; Moskovtsev, A.A.; Morozov, S.G.; Kubatiev, A.A. Phenols and GABAA receptors: From structure and molecular mechanisms action to neuropsychiatric sequelae. Front. Pharmacol. 2024, 15, 1272534. [Google Scholar] [CrossRef] [PubMed]
  132. Guenette, S.; Beaudry, F.; Marier, J.; Vachon, P. Pharmacokinetics anesthetic activity of eugenol in male Sprague–Dawley rats. J. Vet. Pharmacol. Ther. 2006, 29, 265–270. [Google Scholar] [CrossRef] [PubMed]
  133. Nisar, M.F.; Khadim, M.; Rafiq, M.; Chen, J.; Yang, Y.; Wan, C.C. Pharmacological Properties and Health Benefits of Eugenol: A Comprehensive Review. Oxid. Med. Cell. Longev. 2021, 2021, 2497354. [Google Scholar] [CrossRef]
  134. Chung, G.; Oh, S.B. Eugenol as Local Anesthetic. In Natural Products: Phytochemistry, Botany and Metabolism of Alkaloids, Phenolics and Terpenes; Ramawat, K.G., Mérillon, J.M., Eds.; Springer: Berlin, Germany, 2013; pp. 4001–4015. [Google Scholar] [CrossRef]
  135. Tsuchiya, H. Anesthetic Agents of Plant Origin: A Review of Phytochemicals with Anesthetic Activity. Molecules 2017, 22, 1369. [Google Scholar] [CrossRef]
  136. Felix, L.; Monteiro, S.M.; Venêncio, C. Evaluation of thymol application for anaesthesia of adult zebrafish. Fish Physiol. Biochem. 2025, 51, 155. [Google Scholar] [CrossRef]
  137. Grasshoff, C.; Drexler, B.; Rudolph, U.; Antkowiak, B. Anaesthetic drugs: Linking molecular actions to clinical effects. Curr. Pharma. Des. 2006, 12, 3665–3679. [Google Scholar] [CrossRef]
  138. Lee, S.H.; Moon, J.Y.; Jung, S.J.; Kang, J.G.; Choi, S.P.; Jang, J.H. Eugenol inhibits the GABAA current in trigeminal ganglion neurons. PLoS ONE 2015, 10, e0117316. [Google Scholar] [CrossRef] [PubMed]
  139. Soares, G.; Bhattacharya, T.; Chakrabarti, T.; Tagde, P.; Cavalu, S. Exploring Pharmacological Mechanisms of Essential Oils on the Central Nervous System. Plants 2021, 11, 21. [Google Scholar] [CrossRef]
  140. Bakkali, F.; Averbeck, S.; Averbeck, D.; Idaomar, M. Biological effects of essential oils—A review. Food Chem. Toxicol. 2008, 46, 446–475. [Google Scholar] [CrossRef] [PubMed]
  141. Moreira, M.R.C.; Salvadori, M.G.d.S.S.; de Almeida, A.A.C.; de Sousa, D.P.; Jordán, J.; Satyal, P.; de Freitas, R.M.; de Almeida, R.N. Anxiolytic-like effects and mechanism of (−)-myrtenol: A monoterpene alcohol. Neurosci. Lett. 2014, 579, 119–124. [Google Scholar] [CrossRef] [PubMed]
  142. Heldwein, C.G.; de LSilva, L.; Gai, E.Z.; Roman, C.; Parodi, T.V.; Bürger, M.E.; Baldisserotto, B.; de MFlores, É.M.; Heinzmann, B.M. S-(+)-Linalool from Lippia alba: Sedative and anesthetic for silver catfish (Rhamdia quelen). Vet. Anaesth. Analg. 2014, 41, 621–629. [Google Scholar] [CrossRef]
  143. Chioca, L.R.; Ferro, M.M.; Baretta, I.P.; Oliveira, S.M.; Silva, C.R.; Ferreira, J.; Losso, E.M.; Andreatini, R. Anxiolytic-like effect of lavender essential oil inhalation in mice: Participation of serotonergic but not GABAA/benzodiazepine neurotransmission. J. Ethnopharmacol. 2013, 147, 412–418. [Google Scholar] [CrossRef]
  144. Raut, J.S.; Karuppayil, S.M. A status review on the medicinal properties of essential oils. Ind. Crops Prod. 2014, 62, 250–264. [Google Scholar] [CrossRef]
  145. Yang, B.; Piao, Z.; Kim, Y.B.; Lee, C.H.; Lee, J.; Park, K.; Kim, J.; Oh, S. Activation of vanilloid receptor 1 (VR1) by eugenol. J. Dent. Res. 2003, 82, 781–785. [Google Scholar] [CrossRef]
  146. Savio-Galimberti, E.; Gollob, M.H.; Darbar, D. Voltage-gated sodium channels: Biophysics, pharmacology, and related channelopathies. Front. Pharmacol. 2012, 3, 124. [Google Scholar] [CrossRef]
  147. Seo, H.; Li, H.Y.; Perez-Reyes, E.; Lee, J.H. Effects of eugenol on T-type Ca2+ channel isoforms. J. Pharmacol. Exp. Ther. 2013, 347, 310–317. [Google Scholar] [CrossRef]
  148. Park, I.S.; Park, S.J.; Gil, H.W.; Nam, Y.K.; Kim, D.S. Anesthetic effects of clove oil and lidocaine-HCl on marine medaka (Oryzias dancena). Lab. Anim. 2011, 40, 45–51. [Google Scholar] [CrossRef] [PubMed]
  149. Félix, L.; Monteiro, S.M.; Venâncio, C. Menthol as a sustainable alternative anaesthetic for adult zebrafish (Danio rerio). Vet. Res. Commun. 2025, 49, 288. [Google Scholar] [CrossRef]
  150. Conti, F.; Zarantoniello, M.; Antonucci, M.; Cattaneo, N.; Rattin, M.; de Russi, G.; Secci, G.; Lucon-Xiccato, T.; Lira de Medeiros, A.C.; Olivotto, I. The Application of Synthetic Flavors in Zebrafish (Danio rerio) Rearing with Emphasis on Attractive Ones: Effects on Fish Development, Welfare, and Appetite. Animals 2023, 13, 3368. [Google Scholar] [CrossRef]
  151. Polednik, K.M.; Koch, A.C.; Felzien, L.K. Effects of Essential Oil from Thymus vulgaris on Viability and Inflammation in Zebrafish Embryos. Zebrafish 2018, 15, 361–371. [Google Scholar] [CrossRef] [PubMed]
  152. Borges, R.S.; Keita, H.; Ortiz, B.L.S.; dos Santos Sampaio, T.I.; Ferreira, I.M.; Lima, E.S.; Silva, M.J.A.; Fernandes, C.P.; Oliveira, A.E.M.F.M.; da Conceição, E.C.; et al. Anti-inflammatory activity of nanoemulsions of essential oil from Rosmarinus officinalis L.: In vitro and in zebrafish studies. Inflammopharmacology 2018, 26, 1057–1080. [Google Scholar] [CrossRef]
  153. Lanzarin, G.A.B.; Félix, L.M.; Monteiro, S.M.; Ferreira, J.M.; Oliveira, P.A.; Venâncio, C. Anti-Inflammatory, Anti-Oxidative and Anti-Apoptotic Effects of Thymol and 24-Epibrassinolide in Zebrafish Larvae. Antioxidants 2023, 12, 1297. [Google Scholar] [CrossRef]
  154. Akermi, S.; Smaoui, S.; Elhadef, K.; Fourati, M.; Louhichi, N.; Chaari, M.; Chakchouk Mtibaa, A.; Baanannou, A.; Masmoudi, S.; Mellouli, L. Cupressus sempervirens Essential Oil: Exploring the Antibacterial Multitarget Mechanisms, Chemcomputational Toxicity Prediction, and Safety Assessment in Zebrafish Embryos. Molecules 2022, 27, 2630. [Google Scholar] [CrossRef]
  155. Vieira, R.; Venancio, C.; Felix, L. Teratogenic, Oxidative Stress and Behavioural Outcomes of Three Fungicides of Natural Origin (Equisetum arvense, Mimosa tenuiflora, Thymol) on Zebrafish (Danio rerio). Toxics 2021, 9, 8. [Google Scholar] [CrossRef]
  156. Krishnan, M.; Kim, D.K.; Gie Kim, S.; Kang, S.C. Thymol exposure mediates pro-oxidant shift by regulating Nrf2 and apoptotic events in zebrafish (Danio rerio) embryos. Environ. Toxicol. Pharmacol. 2019, 65, 1–8. [Google Scholar] [CrossRef] [PubMed]
  157. da Silva, I.I.; da Silva, N.P.C.; Marrs, J.A.; Cadena, P.G. Essential Oils Produce Developmental Toxicity in Zebrafish Embryos and Cause Behavior Changes in Zebrafish Larvae. Biomedicines 2023, 11, 2821. [Google Scholar] [CrossRef] [PubMed]
  158. Dawood, M.A.; El Basuini, M.F.; Yilmaz, S.; Abdel-Latif, H.M.; Alagawany, M.; Kari, Z.A.; Abdul Razab, M.K.A.; Hamid, N.K.A.; Moonmanee, T.; Van Doan, H. Exploring the roles of dietary herbal essential oils in aquaculture: A review. Animals 2022, 12, 823. [Google Scholar] [CrossRef]
  159. Manayi, A.; Nabavi, S.M.; Daglia, M.; Jafari, S. Natural terpenoids as a promising source for modulation of GABAergic system and treatment of neurological diseases. Pharmacol. Rep. 2016, 68, 671–679. [Google Scholar] [CrossRef]
  160. Kaspute, G.; Ivaskiene, T.; Ramanavicius, A.; Ramanavicius, S.; Prentice, U. Terpenes and Essential Oils in Pharmaceutics: Applications as Therapeutic Agents and Penetration Enhancers with Advanced Delivery Systems for Improved Stability and Bioavailability. Pharmaceutics 2025, 17, 793. [Google Scholar] [CrossRef]
Figure 1. Activation of the hypothalamus–pituitary–interrenal (HPI) axis (A) and the brain–sympathetic–chromaffin (BSC) system (B) after stress exposure in fish.
Figure 1. Activation of the hypothalamus–pituitary–interrenal (HPI) axis (A) and the brain–sympathetic–chromaffin (BSC) system (B) after stress exposure in fish.
Fishes 11 00289 g001
Figure 2. Different environmental, physiological and physical stressors frequently encountered in aquaculture enclosures.
Figure 2. Different environmental, physiological and physical stressors frequently encountered in aquaculture enclosures.
Fishes 11 00289 g002
Figure 3. Anesthetic efficacy of monoterpenes through modulation of transient receptor potential (TRP) channels, voltage-gated ion channels, such as sodium (Na+) and calcium (Ca2+), and gamma-aminobutyric acid (GABA) receptors in fish.
Figure 3. Anesthetic efficacy of monoterpenes through modulation of transient receptor potential (TRP) channels, voltage-gated ion channels, such as sodium (Na+) and calcium (Ca2+), and gamma-aminobutyric acid (GABA) receptors in fish.
Fishes 11 00289 g003
Table 1. Evolution of studies and key findings regarding different stress stimuli and their associated effects in zebrafish (Danio rerio) larvae across different development stages (0 to 120 h post-fertilization (hpf)).
Table 1. Evolution of studies and key findings regarding different stress stimuli and their associated effects in zebrafish (Danio rerio) larvae across different development stages (0 to 120 h post-fertilization (hpf)).
StageStimulusObjectiveObserved EffectFindingsReference
25–97 hpfDifferent stressors (unspecified)Development of corticosteroid axisCortisol synthesis and HPI activation from ~72 hpf
No acute response until 97 hpf
HPI axis becomes functional before 97 hpf[6]
0–97 hpfAcute stress (unspecified)Onset of functional HPI responseBasal cortisol levels present at hatch
Stress-induced response from 97 hpf
Confirms timing of HPI activation in larvae[70]
2, 24, 48 and 96 hpfAcute swirling stressor and light stimulusRole of GR and MR in stress behaviorLoss of GR/MR abolished hyperactivity after light stress
Cortisol increases at 96 hpf
GCR and MR both mediate stress-related behavior[66]
96 hpfAcute swirling stressorMechanisms involving stress responseCRH/CRHR1 system induces hyperactivity
GR/MR sustain response
Cortisol increases
Establishes link between CRH and cortisol signaling[71]
120 hpfVortex flow (medium strength) Prolonged forced swimming and HPI activationWhole-body cortisol increases from the moment of exposure up until 4 h later; return to baseline at 6 h
Positive rheotaxis
Early life stress reconfigures cortisol secretion[72]
Table 2. Overview of synthetic anesthetic substances tested in zebrafish (Danio rerio) embryos (6 to 72 h post-fertilization (hpf)) and larvae (3 to 9 days post-fertilization (dpf)).
Table 2. Overview of synthetic anesthetic substances tested in zebrafish (Danio rerio) embryos (6 to 72 h post-fertilization (hpf)) and larvae (3 to 9 days post-fertilization (dpf)).
CompoundConcentration
(mg L−1)
StageMechanism of ActionMain ObservationsSide EffectsReference
MS-22278.4–2612.94–4.5 dpfNa+ channel blockadeLimited CNS depression at higher concentrations
↓ Brain activity after light stimulation
↓ Atrial and ventricular rates *
↓ Stroke volume *
↓ Cardiac output *
↑ Thigmotaxis in light phase at higher concentrations
↓ Locomotion at lower concentrations
Cardiovascular stress
Anxiogenesis
[103]
500–10003–5 dpf↑ Sensitivity with age due to maturation of ionoregulatory functionStage-dependent sensitivity 
1685–7 dpfRapid loss of tactile response and righting reflex *
Rapid recovery of tactile response *
Interference with optokinetic behavior
Stable heart rate
Behavioral alterations[104]
Propofol1–56 hpf–3 dpf GABA modulation
Conductance of Cl channels
↓ Heart rate
↓ Body length
↓ Hatchability
↑ Expression of casp3a, casp3b, casp9 and baxb
Edema, spinal deformities, fin dysplasia, light pigmentation, hemorrhage
Cardiovascular stress
Developmental toxicity
Malformations
Apoptosis
[105]
Quinaldine sulfate193–1351.14–4.5 dpfUnclearLimited CNS depression at higher concentrations
Aversion to the administration site
↓ Brain activity after light stimulation
↓ Atrial and ventricular rates *
↓ Cardiac output *
↑ Thigmotaxis response
Avoidance behavior
Cardiovascular stress
Anxiogenesis
[103]
Etomidate29.3–537.44–4.5 dpfGABA modulationLimited reduction in brain activity
↓ Atrial and ventricular rates *
↑ Thigmotaxis response at intermediate concentrations
Minimal cardiovascular stress
Anxiogenesis
[103]
Benzocaine≥49.64–4.5 dpfNa+ channel blockadeWidespread CNS depression at higher concentrations
↓ Atrial and ventricular rates * ↓ Cardiac output*
↑ Thigmotaxis in dark phase at higher concentrations
Cardiovascular stress
Anxiogenesis
[103]
↑ Increase. ↓ Decrease. * Concentration-dependent effects.
Table 3. Overview of plant-based substances with anesthetic properties tested in zebrafish (Danio rerio) embryos (24 to 96 h post-fertilization (hpf)) and larvae (3 to 5 days post-fertilization (dpf)).
Table 3. Overview of plant-based substances with anesthetic properties tested in zebrafish (Danio rerio) embryos (24 to 96 h post-fertilization (hpf)) and larvae (3 to 5 days post-fertilization (dpf)).
SubstanceConcentration
(mg L−1)
StageMechanism of ActionMain ObservationsSide EffectsReference
Clove oil40, 60, 90, 120, and 150 24 hpfGABA modulation;
Na+/Ca2+ channel blockade
Rapid anesthesia *
Prolonged recovery *
↑ Mortality with concentration
-[76]
90, 120, and 1505 dpfRapid anesthesia *
Prolonged recovery *
↑ Mortality at 90 and 150 mg/L
Isoeugenol32.8–394.14–4.5 dpfCNS depression at higher concentrations
↓ Atrial and ventricular rates *
↓ Stroke volume *
↓ Cardiac output *
↑ Thigmotaxis response at intermediate concentrations
Cardiovascular stress
Anxiogenesis
[103]
AQUI-S 40, 100, 150 and 20024 hpfRapid anesthesia *
Prolonged recovery *
↑ Mortality with concentration; Lethal at 200 mg/L
Heart edema at higher concentrations
Teratogenesis [76]
100 and 2005 dpf↑ Mortality with concentration Lethal at 200 mg/L
Basil essential oil
(Ocimum basilicum)
50, 100 and 200 24 hpf–4 dpfUnclear↑ Mortality at both higher concentrations
↓ Hatch rate *
↓ Heart rate at both higher concentrations
Pericardial edema, blood congestion and un-looped heart at both higher concentrations
Bradycardia at higher concentrations
Teratogenesis
[123]
Thymol153 dpfGABA modulation;
Na+/Ca2+ channel blockade
↓ Heart rate
↓ ATPase activity
↓ Stress
-[124]
100, 200 and 3003 dpf↓ ATPase activity
Differential activities of antioxidant enzymes
↑ Swimming
Bradycardia on anesthesia induction[122]
Menthol503 dpfTRPV1 agonist;
Na+/Ca2+ channel blockade
↓ Heart rate
↓ ATPase activity
Stress
Modulates Nrf2 expression
-[124]
200, 400 and 5003 dpfDifferential activities of antioxidant enzymes
↑ Speed at 500 mg/L
Bradycardia on anesthesia induction[122]
↑ Increase. ↓ Decrease. * Concentration-dependent effects.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Vieira, R.S.F.; Rocha, C.A.; Venâncio, C.A.S.; Félix, L.M. Monoterpenes as Natural Anesthetics to Mitigate Stress in Fish: Advances Using the Zebrafish Larvae Model. Fishes 2026, 11, 289. https://doi.org/10.3390/fishes11050289

AMA Style

Vieira RSF, Rocha CA, Venâncio CAS, Félix LM. Monoterpenes as Natural Anesthetics to Mitigate Stress in Fish: Advances Using the Zebrafish Larvae Model. Fishes. 2026; 11(5):289. https://doi.org/10.3390/fishes11050289

Chicago/Turabian Style

Vieira, Raquel S. F., Cláudia A. Rocha, Carlos A. S. Venâncio, and Luís M. Félix. 2026. "Monoterpenes as Natural Anesthetics to Mitigate Stress in Fish: Advances Using the Zebrafish Larvae Model" Fishes 11, no. 5: 289. https://doi.org/10.3390/fishes11050289

APA Style

Vieira, R. S. F., Rocha, C. A., Venâncio, C. A. S., & Félix, L. M. (2026). Monoterpenes as Natural Anesthetics to Mitigate Stress in Fish: Advances Using the Zebrafish Larvae Model. Fishes, 11(5), 289. https://doi.org/10.3390/fishes11050289

Article Metrics

Back to TopTop